Molecular Glues

Defining New Biology at the Intersection of Mitochondria and UPS

Mechanism of Molecular Glues

Molecular glues are a class of small molecules that induce proximity or stabilize protein–protein interactions, often between an E3 ubiquitin ligase and a target protein, leading to selective degradation of the target via the ubiquitin-proteasome system. Unlike traditional inhibitors that block the function of a protein, molecular glues work by promoting new protein interactions that would not naturally occur or by enhancing weak or transient interactions.

Mechanism of Molecular Glue-Induced Target Degradation

Figure 2. Molecular glues are small molecules that bind E3 ligases and induces a conformational change such that the E3 ligase can interact with a new target protein promoting its ubiquitination and subsequent degradation.

Therapeutic Promise of Molecular Glues

This mechanism has gained significant attention in targeted protein degradation (TPD), particularly in the development of therapies for cancer and other diseases involving undruggable or pathogenic proteins. One well-known example is the immunomodulatory imide drugs (IMiDs) like thalidomide and its derivatives, which bind to the cereblon E3 ligase complex and promote degradation of transcription factors such as Ikaros and Aiolos. Molecular glues offer a promising strategy for expanding the druggable proteome by leveraging the cell’s own degradation machinery.